Xenon Pharmaceuticals Inc (XENE)
SG&A Expense Growth
0.47%
Quarterly · Period ending:
XENE SG&A Expense Growth
Latest reported0.47%period ending
Latest reported0.47%period ending
XENE Quarterly SG&A Growth (QoQ) (0.00% → 0.47%)
Latest values, visible window
High-resolution chart · PNG
XENE sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 0.466% | |
| 7.9391% | |
| 14.4487% | |
| 0.1975% | |
| 1.082% | |
| 5.7373% | |
| 7.7756% | |
| -13.8955% | |
| 36.7108% | |
| 12.4653% | |
| -1.4449% | |
| 10.5318% | |
| 21.4893% | |
| 12.1633% | |
| -3.715% | |
| 1.4245% | |
| 28.4871% | |
| 1.3008% | |
| 38.4392% | |
| -23.7892% | |
| 54.2711% | |
| 32.2923% | |
| -3.1796% | |
| -3.0816% | |
| -0.3012% | |
| 4.5669% | |
| 17.5926% | |
| 17.0351% | |
| -11.9802% | |
| 29.2406% | |
| 4.644% | |
| -11.0193% | |
| -2.681% | |
| 34.012% | |
| -4.2431% | |
| -3.0573% | |
| -14.3333% | |
| 45.6311% | |
| -18.9432% | |
| 6.1456% | |
| -11.5567% | |
| 20.9317% | |
| 18.6223% | |
| 642.1348% | |
| -90.0503% | |
| 28.705% | |
| 5.6231% | |
| -2.8065% | |
| -5.7103% | |
| 74.9086% | |
| -51.4775% | |
| 19.6605% | |
| 0% | |
| -17.91% | |
| 0% | |
| 0% |